Drug Law Weekly

Cell Therapeutics, Inc. - Drug prolongs survival in women with advanced lung cancer, trial results show

Center for Research in Population Health, Cuernavaca - Dietary vitamin D and calcium involved in development of endometrial cancer

Centre Hospitalier de l'Universite de Robert Debre, Reims - Chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone

CepTor Corp., Inc. - Development-stage biopharmaceutical submits application for orphan drug status for Myodur

Chinese University of Hong Kong - Novel TCM-platinum anticancer agents show high potency and low toxicity

Chonnam National University - Statins decrease restenosis in patients with high C-reactive protein levels

Clavis Pharma - First patient included in phase II study with the cancer drug ELACYT

Codexis, Inc. - Privately held biotech expands alliances in generic-pharmaceutical manufacturing

Cognate Therapeutics, Inc. - Brandon J. Price named CEO of stem-cell-focused biopharmaceutical company

Critical Therapeutics, Inc. - ZYFLO maker announces details of asthma treatment's commercial launch

Curis, Inc. - Drug-development company announces the receipt of second extension of funding from Genentech

Curtin University of Technology, Perth - Lipophilic counter-ions improve benzydamine membrane diffusion

Dana-Farber Cancer Institute, Boston - Errors in chemotherapy orders are rare, but there is still room for improvement

Dana-Farber Cancer Institute, Boston - Herceptin trial shows lower risk of breast cancer recurrence when used following chemotherapy

Drug Abuse - San Francisco Fire Department supplied with OralStat saliva drugs of abuse test

EDAP TMS, SA - Company opens its first HIFU prostate cancer treatment center in Australia

Evanston Hospital - New device brings hope to severe heart disease patients

Exactech, Inc. - U.S. Food and Drug Administration clears Connexion GXL enhanced polyethylene hip acetabular liner

ExonHit Therapeutics - Service, supply deal signed for microarray, RNA splicing technologies

Facilities - Healthcare products company, The Children's Shelter open residential treatment center

Finance - $13.2M in grants awarded for mental health services for older adults

G.B. Pant Hospital, New Delhi - Balloon mitral valvuloplasty feasible under transthoracic echocardiographic guidance

GeneGo, Inc. - U.S. FDA to use systems biology technology for research, review of genomics data

GenoMed - Internet-based clinical trials for influenza and avian influenza begun

GlaxoSmithKline - GSK's hepatitis vaccine has been approved for use in children12 months and older

Glenmark Pharmaceuticals, Ltd. - Formulations facility at Goa approved by three international regulatory agencies

Hiroshima University, Higashi-Hiroshima - Beta-lactamase gene identified from an enterohemorrhagic E. coli O157:H7 outbreak strain

Idera Pharmaceuticals, Inc. - HYB2055 phase II renal cell carcinoma protocol amended

OSI Systems, Inc. - U.S. FDA grants 510(k) approval for sale, distribution of anesthesia systems in U.S. market

Osiris Therapeutics, Inc. - Clearance granted for phase II trial of treatment for acute graft vs. host disease

POZEN, Inc. - Trexima NDA accepted for review by U.S. Food and Drug Administration

Purdue University, West Lafayette - Early awareness might prevent avian flu pandemic

Retractable Technologies, Inc. - Safety needle device company receives U.S. Food and Drug Administration approval

U.S. Food & Drug Administration - IL-4 receptor is promising target for advanced ovarian cancer therapy

U.S. Food & Drug Administration - Pigment yellow 74 is metabolized by rat and human microsomal proteins

University of California, San Diego - OTC nicotine replacement products increase smoking cessation efforts